NCT06508346View on ClinicalTrials.gov

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAV

RecruitingOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
ANCA Associated VasculitisCAR-T Cell Therapy
Interventions
BIOLOGICAL

anti-CD19-CAR-T cells

Intravenous injection

Trial Locations (1)

Unknown

RECRUITING

Children's Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
collaborator

Children's Hospital of Chongqing Medical University

OTHER

lead

The Children's Hospital of Zhejiang University School of Medicine

OTHER